Literature DB >> 35186684

Effects of perioperative managements on ocular surface microbiota in intravitreal injection patients.

Ya-Guang Hu1, Qiong Wu2, Tian-Hui Li3,4, Fang Sui5, Ming Zhang1, Zhen Zhang1, Rui Shi6, Na Hui7, Li Qin1, Li Li1.   

Abstract

AIM: To investigate the effects of on ocular surface microbiota in patients who received intravitreal injections.
METHODS: Samples of ocular surface microbiota were obtained from 41 eyes of 41 patients who visited the Department of Ophthalmology. Patients were separated for three groups. Group A did not receive perioperative managements or intravitreal injection. Group B1 received only once and B2 received more than twice. In operating room, the samples were collected on the ocular surface. Operating taxonomic units (OTUs) clustering and alpha/beta diversity analysis was performed. The microbial 16S rRNA from samples were analyzed using the HiSeq 2500 platform.
RESULTS: Alpha diversity did not differ in each group, and beta diversity differed in the B2 group. Beta diversity showed a significant difference between Group A and B2 (P=0.048). With the perioperative managements before intravitreal injection, the composition and relative abundance were altered. Top 10 microbiota on phylum and genus level, and then microbiota notably changed at genus level were listed. Gram-negative bacteria were varied more. Furthermore, Proteus was not found in Groups A and B1, but it was appeared after the patients received perioperative management and intravitreal injections in Group B2.
CONCLUSION: With the perioperative managements, the balance of microbiota on the ocular surface is destroyed, and relative composition and abundance of microbiota on the ocular surface is obviously altered. The clinical doctors should pay more attention on the consequence of perioperative managements before intravitreal injection. International Journal of Ophthalmology Press.

Entities:  

Keywords:  high-throughput sequencing; intravitreal injection; microbiota; ocular surface; perioperative managements

Year:  2022        PMID: 35186684      PMCID: PMC8818460          DOI: 10.18240/ijo.2022.02.09

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  27 in total

Review 1.  Risks of intravitreous injection: a comprehensive review.

Authors:  Rama D Jager; Lloyd Paul Aiello; Samir C Patel; Emmett T Cunningham
Journal:  Retina       Date:  2004-10       Impact factor: 4.256

2.  Identification of unknown ocular pathogens in clinically suspected eye infections using ribosomal RNA gene sequence analysis.

Authors:  M L G Daroy; J S Lopez; B C L Torres; M J Loy; P M C Tuaño; R R Matias
Journal:  Clin Microbiol Infect       Date:  2010-11-02       Impact factor: 8.067

Review 3.  Topical antibiotics and intravitreal injections.

Authors:  Alex P Hunyor; Rohan Merani; Archie Darbar; Jean-François Korobelnik; Paolo Lanzetta; Annabelle A Okada
Journal:  Acta Ophthalmol       Date:  2017-04-25       Impact factor: 3.761

Review 4.  Application of advanced statistics in ophthalmology.

Authors:  Qiao Fan; Yik-Ying Teo; Seang-Mei Saw
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-01       Impact factor: 4.799

5.  Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis.

Authors:  M G Speaker; F A Milch; M K Shah; W Eisner; B N Kreiswirth
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

6.  Ocular surface microbiota in patients with aqueous tear-deficient dry eye.

Authors:  Jasmine Andersson; Josef K Vogt; Marlene D Dalgaard; Oluf Pedersen; Kim Holmgaard; Steffen Heegaard
Journal:  Ocul Surf       Date:  2020-09-12       Impact factor: 5.033

7.  A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites.

Authors:  Dylan Dodd; Matthew H Spitzer; William Van Treuren; Bryan D Merrill; Andrew J Hryckowian; Steven K Higginbottom; Anthony Le; Tina M Cowan; Garry P Nolan; Michael A Fischbach; Justin L Sonnenburg
Journal:  Nature       Date:  2017-11-22       Impact factor: 49.962

8.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms.

Authors:  J Gregory Caporaso; Christian L Lauber; William A Walters; Donna Berg-Lyons; James Huntley; Noah Fierer; Sarah M Owens; Jason Betley; Louise Fraser; Markus Bauer; Niall Gormley; Jack A Gilbert; Geoff Smith; Rob Knight
Journal:  ISME J       Date:  2012-03-08       Impact factor: 10.302

9.  Conjunctival sac bacterial flora isolated prior to cataract surgery.

Authors:  Chikako Suto; Masahiro Morinaga; Tomoko Yagi; Chieko Tsuji; Hiroshi Toshida
Journal:  Infect Drug Resist       Date:  2012-01-24       Impact factor: 4.003

10.  Infectious postoperative endophthalmitis after cataract surgery performed over 7 years. The role of azithromycin versus ciprofloxacin eye drops.

Authors:  J Tuñí-Picado; A Martínez-Palmer; X Fernández-Sala; J Barceló-Vidal; M Castilla-Martí; Y Cartagena-Guardado; S Grau
Journal:  Rev Esp Quimioter       Date:  2018-10-31       Impact factor: 1.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.